Running Interference: RNAi with Silence Therapeutics' Craig Tooman
Business Of Biotech
00:00
What's the Most Challenging Aspect of Leading a Company?
We are so much in vogue right now, to be honest, that we have more opportunities than we can pursue. So the question really is, where can you provide the most value? And you would expect, that's where i spend my time, trying to figure out where to put that incremental dollar to get incremental return for our owners. Ye e, tell us about your internal clinicala progress. Where are you in terms of te proprietary candidates that you're pursuing? I i'd probably have been as enthusidast as any programm i've seen in my 30 years of pharmoceutical history.
Transcript
Play full episode
